Bonnie Watson Coleman actually said...

This decision is delaying the availability of that medicine, even though the FDA had already taken it through its procedures.

We need to balance both [risks and benefits].

I am particularly concerned how all of those issues impact black women and the black community and black children.

It seems to me that the FDA is relying on--that we rely upon the FDA on the science, on the efficacy of the therapy or the medication, and C...